MusthInsider

Latest On Corbus Pharmaceuticals Holdings, Inc (CRBP):

Updated on: March 19, 2021

Date/Time	Type	Description	Signal
2022-11-08 10:30 EST	News	Corbus Pharmaceuticals GAAP EPS of -$0.07 misses by $0.01	N/A
2022-08-09 22:16 EST	News	Corbus Pharmaceuticals GAAP EPS of -$0.11	N/A
2022-05-11 02:18 EST	News	Corbus Pharmaceuticals GAAP EPS of -$0.08 beats by $0.01	N/A
2022-03-08 11:50 EST	News	Corbus Pharmaceuticals GAAP EPS of -$0.37 beats by $0.03, revenue of $0.88M beats by $0.04M	N/A
2021-11-12 19:24 EST	News	Corbus Pharmaceuticals EPS beats by $0.10, misses on revenue	N/A
2021-07-21 03:17 EST	News	Corbus Pharma gains 9% on licensing deal for monoclonal antibodies in cancer and fibrotic diseases	N/A
2021-07-21 03:15 EST	News	Corbus Pharmaceuticals (CRBP) Investor Presentation - Slideshow	N/A
2021-07-21 03:01 EST	News	STSA, AXLA, CVAC and CRBP among after-hours movers	N/A
2021-07-21 02:55 EST	News	Corbus Pharma hurt by setback in late-stage trial for rare autoimmune disease	N/A
2021-04-20 22:08 EST	News	Corbus completes enrollment in mid-stage autoimmune disease trial	N/A
2021-04-15 18:01 EST	News	Corbus: Assessing If Lenabasum Can Finally Break Through	N/A
2021-03-30 23:42 EST	News	Corbus gives update on late-stage lenabasum trial progress	N/A
2021-03-18 04:27 EST	Financials	Company financials have been released.	Neutral
2021-03-17 21:09 EST	News	Corbus Pharmaceuticals Holdings, Inc. 2020 Q4 - Results - Earnings Call Presentation	N/A
2021-03-17 12:26 EST	Analyst Rating	The Analyst Target Price has increased from $2.02 to $2.23.	Buy
2021-03-16 22:27 EST	News	Corbus Pharmaceuticals EPS beats by $0.13, misses on revenue	N/A
2021-03-16 22:27 EST	News	Corbus hints at potential pipeline expansion deals, shares rise	N/A
2021-03-16 22:26 EST	News	Corbus Pharmaceuticals Holdings, Inc. (CRBP) CEO Yuval Cohen on Q4 2020 Results - Earnings Call Transcript	N/A
2021-03-16 20:33 EST	Earnings Estimate	An EPS average of -$0.86 is estimated for the 2022 year.	Sell
2021-03-16 20:33 EST	Earnings Estimate	An EPS average of -$0.13 is estimated for the quarter ending on June 30, 2021.	Sell
2021-03-16 20:33 EST	Analyst Rating	The Analyst Target Price has increased from $1.88 to $2.02.	Neutral
2021-03-05 17:49 EST	News	Seeking Alpha Catalyst Watch	N/A
2021-02-06 16:40 EST	News	Marijuana as medicine: the other cannabinoid pharma players	N/A
2021-02-03 00:04 EST	News	INO, VXRT, BTU and TTM among premarket gainers	N/A
2021-01-29 16:16 EST	News	Corbus Pharmaceuticals: Down But Not Out	N/A
2021-01-11 11:26 EST	Analyst Rating	The Analyst Target Price has decreased from $6.9 to $1.88.	Neutral
2020-12-13 03:41 EST	Financials	Company financials have been released.	Neutral
2020-11-12 03:33 EST	Financials	Company financials have been released.	Neutral
2020-11-11 16:26 EST	News	Corbus Pharmaceuticals Holdings, Inc. (CRBP) CEO Yuval Cohen on Q3 2020 Results - Earnings Call Transcript	N/A
2020-11-11 03:31 EST	Earnings Estimate	An EPS average of -$0.26 is estimated for the quarter ending on March 31, 2021.	Buy
2020-11-10 10:45 EST	News	Corbus's lenabasum shows benefit in autoimmune disorder	N/A
2020-11-10 10:45 EST	News	Lenabasum Exposure Wipes Shareholder Upside For Corbus Pharmaceuticals	N/A
2020-11-10 10:45 EST	News	Corbus Pharmaceutical (CRBP) Phase 3 data lenabasum in systemic sclerosis - Slideshow	N/A
2020-11-10 10:43 EST	News	Corbus Pharmaceuticals down 4% after Q2 miss; top-line down 52%	N/A
2020-11-10 10:43 EST	News	Corbus Pharmaceuticals Holdings, Inc.'s (CRBP) CEO Yuval Cohen On Q3 2020 Results - Quick Version Earnings Call Transcript	N/A
2020-11-07 15:29 EST	Financials	Company financials have been released.	Neutral
2020-10-23 23:06 EST	News	Abnormality in control group flagged as possible reason for failed study of Corbus Pharma's lenabasum	N/A
2020-10-13 12:28 EST	Analyst Rating	The Analyst Target Price has decreased from $7.5 to $6.9.	Neutral
2020-10-08 20:40 EST	News	Corbus Pharma to ax 54% of workforce in cost-cutting move	N/A
2020-10-08 16:29 EST	Analyst Rating	The Analyst Target Price has decreased from $7.74 to $7.5.	Neutral
2020-10-07 16:39 EST	Analyst Rating	The Analyst Target Price has decreased from $8.3 to $7.74.	Neutral
2020-10-07 15:04 EST	News	Roth Capital cuts target price for Corbus Pharmaceuticals	N/A
2020-10-06 08:11 EST	News	Corbus Pharma's lenabasum flunks mid-stage cystic fibrosis study; shares down 30%	N/A
2020-09-26 12:26 EST	Financials	Company financials have been released.	Neutral
2020-09-17 04:34 EST	Financials	Company financials have been released.	Neutral
2020-09-10 08:25 EST	Analyst Rating	The Analyst Target Price has decreased from $13.75 to $8.3.	Neutral
2020-09-09 12:25 EST	Analyst Rating	The Analyst Target Price has decreased from $25.14 to $13.75.	Neutral
2020-09-08 10:14 EST	News	Corbus Pharma's lenabasum flunks late-stage systemic sclerosis study, shares down 77%	N/A
2020-09-05 00:30 EST	Financials	Company financials have been released.	Neutral
2020-08-21 20:33 EST	News	Corbus Pharmaceuticals: Ultra High Implied Volatility Brings Opportunity	N/A

About Corbus Pharmaceuticals Holdings, Inc (CRBP):

Corbus Pharmaceuticals Holdings, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. Its lead product candidate is lenabasum, a synthetic oral endocannabinoid drug that is in Phase III clinical trials for the treatment of systemic sclerosis and dermatomyositis, and in Phase IIb clinical trials to treat systemic lupus erythematosus and cystic fibrosis. The company is also developing CRB-4001, a peripherally-restricted CB1 inverse agonist, for nonalcoholic steatohepatitis and other fibrotic diseases. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, which includes the Jenrin library of approximately 600 compounds and multiple issued and pending patent filings; and strategic collaboration with Kaken Pharmaceutical Co., Ltd. for the development and commercialization of lenabasum in Japan. The company was founded in 2009 and is based in Norwood, Massachusetts.

See Advanced Chart

General

Name Corbus Pharmaceuticals Holdings, Inc
Symbol CRBP
Type Common Stock
Exchange NASDAQ
Currency USD
Country USA
SectorHealthcare
IndustryBiotechnology
Full Time Employees 76
Fiscal Year EndDecember
IPO Date2014-11-11
Gic SectorHealth Care
Gic GroupPharmaceuticals, Biotechnology & Life Sciences
Gic IndustryBiotechnology
Gic SubIndustryBiotechnology
Web URLhttp://www.corbuspharma.com

Valuation

Price/Sales (Trailing 12 Mt.) 44.06
Price/Book (Most Recent Quarter) 6.13
Enterprise Value Revenue 55.56

Financials

Most Recent Quarter 2020-12-31
Current Year EPS Estimate -$0.51
Next Year EPS Estimate -$0.47
Next Quarter EPS Estimate -$0.15
Operating Margin -3119%
Return on Assets -101%
Return on Equity -433%
Revenue 3.94 million
Earnings Per Share -$0.93
Revenue Per Share $0.05
Gross Profit -94329983
Quarterly Earnings Growth -74.4%

Highlights

Market Capitalization 269.86 million
EBITDA -56710588
PE Ratio -16.14
Analyst Target Price $2.23
Book Value Per Share $0.46

Share Statistics

Shares Outstanding 124.94 million
Shares Float 115.36 million
% Held by Insiders 173%
% Held by Institutions 75.49%
Shares Short 13.58 million
Shares Short Prior Month 22.14 million
Short Ratio 0.52
Short % of Float 20%
Short % of Shares Outstanding 16%

Technicals

Beta 2
52 Week High $9.78
52 Week Low $0.91
50 Day Moving Average 2.48
200 Day Moving Average 1.98

Dividends

Dividend Date N/A
ExDividend Date N/A
Dividend Yield 0%

Corbus Pharmaceuticals Holdings, Inc (CRBP) Dividend Calendar:

Ex-Dividend Date	Payment Date	Record Date	Declared Date	Amount

Corbus Pharmaceuticals Holdings, Inc (CRBP) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.

Quarter Date	Report Date	Actual Revenue	Reported EPS	EPS Estimate	Deviation from Estimate
2020-12-31	2021-03-15	$658204	-$0.10	-$0.25	60%
2020-09-30	2020-11-09	$N/A	-$0.43	-$0.41	-5.91%
2020-06-30	2020-08-06	$N/A	-$0.52	-$0.38	-38.67%
2020-03-31	2020-05-11	$1.76 million	-$0.43	-$0.42	-1.58%
2019-12-31	2020-03-12	$2.57 million	-$0.41	-$0.36	-14.53%
2019-09-30	2019-11-07	$2.59 million	-$0.32	-$0.36	11.92%
2019-06-30	2019-08-08	$29.09 million	$0.03	-$0.36	108.43%
2019-03-31	2019-05-09	$1.89 million	-$0.43	-$0.15	-189.95%
2018-12-31	2019-03-12	$1.93 million	-$0.31	-$0.27	-16.24%
2018-09-30	2018-11-08	$1.09 million	-$0.26	-$0.22	-17.28%
2018-06-30	2018-08-08	$853646	-$0.21	-$0.22	2.33%
2018-03-31	2018-05-10	$950442	-$0.21	-$0.15	-44.83%
2017-12-31	2018-03-12	$1.64 million	-$0.21	-$0.15	-36.36%
2017-09-30	2017-11-08	$796000	-$0.14	-$0.16	12.5%
2017-06-30	2017-08-09	$350000	-$0.15	-$0.19	19.66%
2017-03-31	2017-05-09	$1.29 million	-$0.16	-$0.16	0%
2016-12-31	2017-03-08	$375000	-$0.18	-$0.14	-31.68%
2016-09-30	2016-11-10	$743000	-$0.12	-$0.11	-9.09%
2016-06-30	2016-08-12	$396000	-$0.11	-$0.08	-46.67%
2016-03-31	2016-05-13	$397000	-$0.08	-$0.08	0%
2015-12-31	2016-03-28	$364000	-$0.06	-$0.07	17.24%
2015-09-30	2015-11-11	$170000	-$0.06	-$0.08	25%
2015-06-30	2015-08-13	$114000	-$0.10
2015-03-31	2015-05-13	$N/A	-$0.06
2014-12-31	2015-02-10	$N/A	-$0.05

Corbus Pharmaceuticals Holdings, Inc (CRBP) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:

Date	Dec 31 2020	Sep 30 2020	Jun 30 2020	Mar 31 2020	Dec 31 2019
Research Development	16.11 million	N/A	N/A	23.95 million	N/A
Income Before Tax	-8.61 million	N/A	N/A	-29.66 million	-26.58 million
Selling General Administrative	5.36 million	N/A	N/A	7.7 million	6.28 million
Gross Profit	N/A	N/A	N/A	N/A	-20.91 million
Ebit	-20.38 million	N/A	N/A	-29.43 million	-27.19 million
Operating Income	-20.81 million	N/A	N/A	-29.89 million	-27.19 million
Income Tax Expense	N/A	N/A	N/A	N/A	N/A
Total Revenue	658204	N/A	N/A	1.76 million	2.57 million
Cost of Revenue	N/A	N/A	N/A	N/A	23.49 million
Total Other Income Expense Net	12.88 million	N/A	N/A	126493	609550
Net Income From Continuing Operations	-8.61 million	N/A	N/A	-29.66 million	-26.58 million
Net Income Applicable to Common Shares	-8.61 million	-34.9 million	-38.11 million	N/A	-26.58 million

Cash Flow:

Date	Sep 30 2020	Jun 30 2020	Mar 31 2020	Dec 31 2019	Sep 30 2019
Investments	N/A	N/A	-463605	N/A	N/A
Change to Liabilities	3.32 million	-2.02 million	N/A	N/A	N/A
Total Cash Flow from Investing Activities	-56798	-16174	N/A	N/A	N/A
Net Borrowings	18.65 million	-323969	N/A	N/A	N/A
Total Cash Flow from Financial Activities	N/A	N/A	42.93 million	N/A	N/A
Change to Operating Activities	988324	5.23 million	N/A	N/A	N/A
Change in Cash	N/A	N/A	14.87 million	N/A	N/A
Total Cash from Operating Activities	-27.25 million	-26.61 million	-27.6 million	N/A	N/A
Depreciation	N/A	N/A	458004	N/A	N/A
Other Cash Flow from Investing Activities	N/A	N/A	N/A	N/A	N/A
Change to Inventory	N/A	N/A	N/A	N/A	N/A
Change to Account Receivables	N/A	N/A	N/A	N/A	N/A
Other Cash Flow from Financing Activities	-2.41 million	-189873	N/A	N/A	N/A
Change to Net Income	3.83 million	3.39 million	N/A	N/A	N/A
Capital Expenditures	N/A	N/A	463605	N/A	N/A

Balance Sheet:

Date	Dec 31 2020	Sep 30 2020	Jun 30 2020	Mar 31 2020	Dec 31 2019
Total Liabailities	57.02 million	N/A	N/A	42.51 million	42.98 million
Total Stockholder Equity	45.27 million	N/A	N/A	22.69 million	6.16 million
Other Current Liabilities	797000	757000	N/A	N/A	N/A
Total Assets	102.29 million	N/A	N/A	65.2 million	49.14 million
Common Stock	9885	8220	8065	N/A	6467
Other Current Assets	350000	350000	N/A	N/A	N/A
Retained Earnings	-304.09 million	-295.48 million	-260.59 million	-222.48 million	-192.82 million
Other Liabilities	N/A	N/A	N/A	N/A	N/A
Other Assets	903938	682941	14085	N/A	84968
Cash	85.43 million	N/A	N/A	46.62 million	31.75 million
Total Current Liabilities	31.9 million	41.4 million	N/A	34.65 million	34.89 million
Other Stockholder Equity	N/A	N/A	N/A	N/A	N/A
Property, Plant & Equipment	9.32 million	9.8 million	10.09 million	N/A	10.9 million
Total Current Assets	92.07 million	85.36 million	N/A	54.66 million	38.15 million
Long Term Investments	N/A	N/A	N/A	N/A	N/A
Net Tangible Assets	45.27 million	29.23 million	48.41 million	N/A	6.16 million
Short Term Investments	N/A	N/A	N/A	N/A	N/A
Long Term Debt	18.03 million	N/A	N/A	N/A	N/A
Inventory	N/A	N/A	N/A	N/A	N/A
Accounts Payable	7.38 million	11.08 million	N/A	9.96 million	11.09 million

Corbus Pharmaceuticals Holdings, Inc (CRBP) Chart:

Corbus Pharmaceuticals Holdings, Inc (CRBP) News:

Below you will find a list of latest news for Corbus Pharmaceuticals Holdings, Inc (CRBP) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Corbus Pharmaceuticals Holdings, Inc (CRBP) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date:

Options Type:

Moneyness:

Expiration Date	Strike	Last Price	Type	Volume	Open Interest	Implied Volatility	In The Money	Change	Change Percent
2026-07-17	2.5	0	CALL	0	0	0	TRUE	0	0
2026-07-17	5	0	CALL	0	1	61.71	TRUE	0	0
2026-07-17	7.5	0	CALL	0	14	234.41	TRUE	0	0
2026-07-17	10	0.65	CALL	490	6190	86.09	FALSE	0.25	0.63
2026-07-17	12.5	0	CALL	0	0	154.14	FALSE	0	0
2026-07-17	15	0	CALL	0	500	427.91	FALSE	0	0
2026-07-17	17.5	0	CALL	0	5	460.95	FALSE	0	0
2026-07-17	20	0	CALL	0	0	488	FALSE	0	0
2026-07-17	22.5	0	CALL	0	0	510.83	FALSE	0	0
2026-07-17	2.5	0	PUT	0	20	687.8	FALSE	0	0
2026-07-17	5	0	PUT	0	52	113.56	FALSE	0	0
2026-07-17	7.5	0	PUT	0	245	94.39	FALSE	0	0
2026-07-17	10	0	PUT	0	2	146.5	TRUE	0	0
2026-07-17	12.5	0	PUT	0	0	120.31	TRUE	0	0
2026-07-17	15	0	PUT	0	0	128.94	TRUE	0	0
2026-07-17	17.5	0	PUT	0	0	128.48	TRUE	0	0
2026-07-17	20	0	PUT	0	0	147.75	TRUE	0	0
2026-07-17	22.5	0	PUT	0	0	164.48	TRUE	0	0
2026-08-21	2.5	0	CALL	0	0	0	TRUE	0	0
2026-08-21	5	0	CALL	0	0	107.32	TRUE	0	0
2026-08-21	7.5	0	CALL	0	0	169.11	TRUE	0	0
2026-08-21	10	0.95	CALL	1	0	137.47	FALSE	0.95	0
2026-08-21	12.5	0	CALL	0	0	259.05	FALSE	0	0
2026-08-21	15	0	CALL	0	0	287.51	FALSE	0	0
2026-08-21	2.5	0	PUT	0	0	1247.4	FALSE	0	0
2026-08-21	5	0	PUT	0	0	400.2	FALSE	0	0
2026-08-21	7.5	0	PUT	0	0	223.91	FALSE	0	0
2026-08-21	10	2.55	PUT	1	0	122.32	TRUE	2.55	0
2026-08-21	12.5	0	PUT	0	0	123.02	TRUE	0	0
2026-08-21	15	0	PUT	0	0	126.06	TRUE	0	0
2026-09-18	2.5	0	CALL	0	2	0	TRUE	0	0
2026-09-18	5	0	CALL	0	727	0	TRUE	0	0
2026-09-18	7.5	0	CALL	0	92	137.03	TRUE	0	0
2026-09-18	10	1.51	CALL	2	209	112.69	FALSE	1.51	0
2026-09-18	12.5	0	CALL	0	2220	128.68	FALSE	0	0
2026-09-18	15	0	CALL	0	132	145.25	FALSE	0	0
2026-09-18	17.5	0	CALL	0	21	157.88	FALSE	0	0
2026-09-18	20	0	CALL	0	785	165.02	FALSE	0	0
2026-09-18	22.5	0.3	CALL	1	25	286.12	FALSE	0.3	0
2026-09-18	2.5	0.2	PUT	10	60	137.99	FALSE	0.2	0
2026-09-18	5	0	PUT	0	4	129.73	FALSE	0	0
2026-09-18	7.5	0	PUT	0	60	74.58	FALSE	0	0
2026-09-18	10	0	PUT	0	25	89.21	TRUE	0	0
2026-09-18	12.5	0	PUT	0	7	124.08	TRUE	0	0
2026-09-18	15	0	PUT	0	8	123.34	TRUE	0	0
2026-09-18	17.5	0	PUT	0	0	133.19	TRUE	0	0
2026-09-18	20	0	PUT	0	0	143.41	TRUE	0	0
2026-09-18	22.5	0	PUT	0	0	127.41	TRUE	0	0
2026-12-18	2.5	0	CALL	0	19	112.24	TRUE	0	0
2026-12-18	5	0	CALL	0	10	102.81	TRUE	0	0
2026-12-18	7.5	0	CALL	0	230	106.7	TRUE	0	0
2026-12-18	10	0	CALL	0	25	130.87	FALSE	0	0
2026-12-18	12.5	1.54	CALL	0	198	114.34	FALSE	0	0
2026-12-18	15	1.1	CALL	4	3924	115.91	FALSE	1.1	0
2026-12-18	17.5	0	CALL	0	863	132.28	FALSE	0	0
2026-12-18	20	0.85	CALL	40	7066	121.44	FALSE	0.85	0
2026-12-18	22.5	0	CALL	0	3594	110.46	FALSE	0	0
2026-12-18	2.5	0	PUT	0	1	273.3	FALSE	0	0
2026-12-18	5	0	PUT	0	6	98.99	FALSE	0	0
2026-12-18	7.5	0	PUT	0	14	83.05	FALSE	0	0
2026-12-18	10	4.15	PUT	5	7	129.59	TRUE	4.15	0
2026-12-18	12.5	0	PUT	0	18	115.38	TRUE	0	0
2026-12-18	15	0	PUT	0	4	115.77	TRUE	0	0
2026-12-18	17.5	0	PUT	0	0	125.18	TRUE	0	0
2026-12-18	20	0	PUT	0	3	116.34	TRUE	0	0
2026-12-18	22.5	0	PUT	0	0	116.98	TRUE	0	0

Latest CRBP Trades:

Date	Shares	Price
Jun 13, 2022 6:21 PM EST	267	$0.2624
Jun 13, 2022 6:21 PM EST	300	$0.2624
Jun 13, 2022 6:23 PM EST	50	$0.2624
Jun 13, 2022 6:24 PM EST	50	$0.2624
Jun 13, 2022 6:24 PM EST	50	$0.2624

Corbus Pharmaceuticals Holdings, Inc (CRBP) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Form Type:

Date	Form Type	Form Name	Link
2020-05-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919120031663/0001209191-20-031663-index.htm
2019-06-10	UPLOAD	SEC-generated letter	https://www.sec.gov/Archives/edgar/data/1595097/000000000019009641/0000000000-19-009641-index.htm
2019-07-15	UPLOAD	SEC-generated letter	https://www.sec.gov/Archives/edgar/data/1595097/000000000019011115/0000000000-19-011115-index.htm
2020-04-13	UPLOAD	SEC-generated letter	https://www.sec.gov/Archives/edgar/data/1595097/000000000020003171/0000000000-20-003171-index.htm
2020-10-13	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1595097/000009375120000967/0000093751-20-000967-index.htm
2019-02-04	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1595097/000021545719003233/0000215457-19-003233-index.htm
2020-02-05	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1595097/000083423720005448/0000834237-20-005448-index.htm
2019-02-14	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1595097/000090571819000212/0000905718-19-000212-index.htm
2020-02-14	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1595097/000110465920021777/0001104659-20-021777-index.htm
2019-02-14	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1595097/000114420419007532/0001144204-19-007532-index.htm
2018-05-16	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919118030426/0001209191-18-030426-index.htm
2018-05-29	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919118033766/0001209191-18-033766-index.htm
2018-05-29	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919118033770/0001209191-18-033770-index.htm
2018-05-29	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919118033772/0001209191-18-033772-index.htm
2018-05-29	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919118033781/0001209191-18-033781-index.htm
2018-06-06	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919118035974/0001209191-18-035974-index.htm
2018-06-06	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919118035975/0001209191-18-035975-index.htm
2018-11-16	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919118058931/0001209191-18-058931-index.htm
2019-01-18	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919119004573/0001209191-19-004573-index.htm
2019-01-18	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919119004574/0001209191-19-004574-index.htm
2019-01-18	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919119004577/0001209191-19-004577-index.htm
2019-01-18	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919119004579/0001209191-19-004579-index.htm
2019-03-04	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919119015953/0001209191-19-015953-index.htm
2019-03-04	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919119015958/0001209191-19-015958-index.htm
2019-03-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919119019345/0001209191-19-019345-index.htm
2019-03-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919119019352/0001209191-19-019352-index.htm
2019-03-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919119019374/0001209191-19-019374-index.htm
2019-03-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919119019602/0001209191-19-019602-index.htm
2019-03-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919119019614/0001209191-19-019614-index.htm
2019-03-18	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919119019885/0001209191-19-019885-index.htm
2019-04-08	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919119023973/0001209191-19-023973-index.htm
2019-04-08	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919119023975/0001209191-19-023975-index.htm
2019-05-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919119029514/0001209191-19-029514-index.htm
2019-05-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919119029556/0001209191-19-029556-index.htm
2019-05-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919119029852/0001209191-19-029852-index.htm
2019-05-20	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919119031229/0001209191-19-031229-index.htm
2019-06-28	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919119039459/0001209191-19-039459-index.htm
2019-06-28	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919119039463/0001209191-19-039463-index.htm
2019-06-28	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919119039465/0001209191-19-039465-index.htm
2019-06-28	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919119039467/0001209191-19-039467-index.htm
2019-06-28	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919119039468/0001209191-19-039468-index.htm
2019-06-28	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919119039469/0001209191-19-039469-index.htm
2019-08-08	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919119045052/0001209191-19-045052-index.htm
2019-08-08	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919119045053/0001209191-19-045053-index.htm
2019-08-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919119045442/0001209191-19-045442-index.htm
2019-08-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919119045444/0001209191-19-045444-index.htm
2019-08-13	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919119045684/0001209191-19-045684-index.htm
2019-08-13	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919119045697/0001209191-19-045697-index.htm
2019-08-16	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919119046252/0001209191-19-046252-index.htm
2019-11-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919119055918/0001209191-19-055918-index.htm
2019-11-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919119055930/0001209191-19-055930-index.htm
2019-11-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919119055941/0001209191-19-055941-index.htm
2019-11-13	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919119056260/0001209191-19-056260-index.htm
2020-03-09	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919120017383/0001209191-20-017383-index.htm
2020-03-09	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919120017393/0001209191-20-017393-index.htm
2020-03-09	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919120017400/0001209191-20-017400-index.htm
2020-03-09	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919120017408/0001209191-20-017408-index.htm
2020-03-09	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919120017413/0001209191-20-017413-index.htm
2020-03-17	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919120019502/0001209191-20-019502-index.htm
2020-03-18	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919120019914/0001209191-20-019914-index.htm
2020-03-18	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919120019931/0001209191-20-019931-index.htm
2020-03-18	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919120019954/0001209191-20-019954-index.htm
2020-05-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919120031658/0001209191-20-031658-index.htm
2020-05-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919120031659/0001209191-20-031659-index.htm
2020-05-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919120031660/0001209191-20-031660-index.htm
2020-05-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919120031661/0001209191-20-031661-index.htm
2020-05-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919120031662/0001209191-20-031662-index.htm
2020-05-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000120919120031663/0001209191-20-031663-index.htm
2019-12-02	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1595097/000121390019025087/0001213900-19-025087-index.htm
2020-03-19	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1595097/000121390020006823/0001213900-20-006823-index.htm
2020-04-24	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1595097/000121390020010018/0001213900-20-010018-index.htm
2020-08-07	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1595097/000121390020020809/0001213900-20-020809-index.htm
2020-11-06	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1595097/000121390020035462/0001213900-20-035462-index.htm
2018-05-24	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1595097/000149315218007765/0001493152-18-007765-index.htm
2018-06-06	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1595097/000149315218008253/0001493152-18-008253-index.htm
2018-06-13	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1595097/000149315218008575/0001493152-18-008575-index.htm
2018-07-25	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1595097/000149315218010415/0001493152-18-010415-index.htm
2018-08-08	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1595097/000149315218011138/0001493152-18-011138-index.htm
2018-08-08	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1595097/000149315218011140/0001493152-18-011140-index.htm
2018-09-20	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1595097/000149315218013520/0001493152-18-013520-index.htm
2018-11-08	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1595097/000149315218015410/0001493152-18-015410-index.htm
2018-11-08	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1595097/000149315218015417/0001493152-18-015417-index.htm
2019-01-03	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1595097/000149315219000082/0001493152-19-000082-index.htm
2019-01-24	424B5	Prospectus [Rule 424(b)(5)]	https://www.sec.gov/Archives/edgar/data/1595097/000149315219000901/0001493152-19-000901-index.htm
2019-01-25	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1595097/000149315219000956/0001493152-19-000956-index.htm
2019-01-28	424B5	Prospectus [Rule 424(b)(5)]	https://www.sec.gov/Archives/edgar/data/1595097/000149315219001023/0001493152-19-001023-index.htm
2019-01-30	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1595097/000149315219001156/0001493152-19-001156-index.htm
2019-03-12	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1595097/000149315219003129/0001493152-19-003129-index.htm
2019-03-12	10-K	Annual report [Section 13 and 15(d), not S-K Item 405]	https://www.sec.gov/Archives/edgar/data/1595097/000149315219003143/0001493152-19-003143-index.htm
2019-03-12	S-8	Securities to be offered to employees in employee benefit plans	https://www.sec.gov/Archives/edgar/data/1595097/000149315219003206/0001493152-19-003206-index.htm
2019-04-01	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1595097/000149315219004518/0001493152-19-004518-index.htm
2019-04-08	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1595097/000149315219005015/0001493152-19-005015-index.htm
2019-04-10	DEF 14A	Other definitive proxy statements	https://www.sec.gov/Archives/edgar/data/1595097/000149315219005114/0001493152-19-005114-index.htm
2019-04-10	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	https://www.sec.gov/Archives/edgar/data/1595097/000149315219005115/0001493152-19-005115-index.htm
2019-04-18	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1595097/000149315219005599/0001493152-19-005599-index.htm
2019-05-09	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1595097/000149315219006607/0001493152-19-006607-index.htm
2019-05-09	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1595097/000149315219006611/0001493152-19-006611-index.htm
2019-05-23	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1595097/000149315219008125/0001493152-19-008125-index.htm
2019-06-25	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1595097/000149315219009707/0001493152-19-009707-index.htm
2019-08-08	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1595097/000149315219011831/0001493152-19-011831-index.htm
2019-08-08	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1595097/000149315219011835/0001493152-19-011835-index.htm
2019-11-07	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1595097/000149315219016583/0001493152-19-016583-index.htm
2019-11-07	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1595097/000149315219016601/0001493152-19-016601-index.htm
2019-11-25	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1595097/000149315219018312/0001493152-19-018312-index.htm
2020-02-06	424B5	Prospectus [Rule 424(b)(5)]	https://www.sec.gov/Archives/edgar/data/1595097/000149315220001701/0001493152-20-001701-index.htm
2020-02-07	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1595097/000149315220001766/0001493152-20-001766-index.htm
2020-02-10	424B5	Prospectus [Rule 424(b)(5)]	https://www.sec.gov/Archives/edgar/data/1595097/000149315220001838/0001493152-20-001838-index.htm
2020-03-10	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1595097/000149315220003644/0001493152-20-003644-index.htm
2020-03-10	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000149315220003662/0001493152-20-003662-index.htm
2020-03-10	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000149315220003663/0001493152-20-003663-index.htm
2020-03-12	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1595097/000149315220003772/0001493152-20-003772-index.htm
2020-03-16	10-K	Annual report [Section 13 and 15(d), not S-K Item 405]	https://www.sec.gov/Archives/edgar/data/1595097/000149315220004077/0001493152-20-004077-index.htm
2020-03-17	S-8	Securities to be offered to employees in employee benefit plans	https://www.sec.gov/Archives/edgar/data/1595097/000149315220004157/0001493152-20-004157-index.htm
2020-04-01	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1595097/000149315220005602/0001493152-20-005602-index.htm
2020-04-07	S-3	Registration statement under Securities Act of 1933	https://www.sec.gov/Archives/edgar/data/1595097/000149315220005953/0001493152-20-005953-index.htm
2020-04-07	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1595097/000149315220005955/0001493152-20-005955-index.htm
2020-04-09	DEF 14A	Other definitive proxy statements	https://www.sec.gov/Archives/edgar/data/1595097/000149315220006110/0001493152-20-006110-index.htm
2020-04-09	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	https://www.sec.gov/Archives/edgar/data/1595097/000149315220006111/0001493152-20-006111-index.htm
2020-04-21	8-K/A	Current report	https://www.sec.gov/Archives/edgar/data/1595097/000149315220006836/0001493152-20-006836-index.htm
2020-04-24	S-3/A	Registration statement under Securities Act of 1933	https://www.sec.gov/Archives/edgar/data/1595097/000149315220007094/0001493152-20-007094-index.htm
2020-04-24	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1595097/000149315220007096/0001493152-20-007096-index.htm
2020-04-30	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1595097/000149315220007445/0001493152-20-007445-index.htm
2020-05-04	424B3	Prospectus [Rule 424(b)(3)]	https://www.sec.gov/Archives/edgar/data/1595097/000149315220007596/0001493152-20-007596-index.htm
2020-05-11	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1595097/000149315220008150/0001493152-20-008150-index.htm
2020-05-11	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1595097/000149315220008248/0001493152-20-008248-index.htm
2020-05-21	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1595097/000149315220009623/0001493152-20-009623-index.htm
2020-07-08	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1595097/000149315220012800/0001493152-20-012800-index.htm
2020-07-08	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000149315220012801/0001493152-20-012801-index.htm
2020-07-08	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1595097/000149315220012802/0001493152-20-012802-index.htm
2020-07-29	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1595097/000149315220014133/0001493152-20-014133-index.htm
2020-08-06	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1595097/000149315220014810/0001493152-20-014810-index.htm
2020-08-06	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1595097/000149315220014895/0001493152-20-014895-index.htm
2020-08-07	424B5	Prospectus [Rule 424(b)(5)]	https://www.sec.gov/Archives/edgar/data/1595097/000149315220014902/0001493152-20-014902-index.htm
2020-08-07	424B5	Prospectus [Rule 424(b)(5)]	https://www.sec.gov/Archives/edgar/data/1595097/000149315220014904/0001493152-20-014904-index.htm
2020-08-31	10-Q/A	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1595097/000149315220017022/0001493152-20-017022-index.htm
2020-09-08	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1595097/000149315220017365/0001493152-20-017365-index.htm
2020-09-15	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1595097/000149315220017794/0001493152-20-017794-index.htm
2020-09-25	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1595097/000149315220018325/0001493152-20-018325-index.htm
2020-10-06	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1595097/000149315220018978/0001493152-20-018978-index.htm
2020-10-08	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1595097/000149315220019126/0001493152-20-019126-index.htm
2018-10-29	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1595097/000161577418011405/0001615774-18-011405-index.htm
2019-02-19	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1595097/000161577419002673/0001615774-19-002673-index.htm
2019-04-29	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1595097/000161577419006505/0001615774-19-006505-index.htm
2019-06-03	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1595097/000161577419009075/0001615774-19-009075-index.htm
2020-05-01	EFFECT	Notice of Effectiveness	https://www.sec.gov/Archives/edgar/data/1595097/999999999520001005/9999999995-20-001005-index.htm
2018-12-04	CT ORDER	Confidential treatment order	https://www.sec.gov/Archives/edgar/data/1595097/999999999718009293/9999999997-18-009293-index.htm
2019-03-04	CT ORDER	Confidential treatment order	https://www.sec.gov/Archives/edgar/data/1595097/999999999719000685/9999999997-19-000685-index.htm

Corbus Pharmaceuticals Holdings, Inc (CRBP) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Corbus Pharmaceuticals Holdings, Inc (CRBP). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 173%
Institutional Ownership: 7549%

Transaction Date	Insider Name	Insider Title	Type	Shares Number	Shares Price	Total Transaction	Shares Held After Transaction	Link
2019-03-15	John Kenneth Jenkins	Director	Buy	1,000.00	6.98	6,977.90	1,000.00	https://www.sec.gov/Archives/edgar/data/1595097/000120919119019614/0001209191-19-019614-index.htm
2019-11-11	Craig Stuart Millian	Chief Commercial Officer	Buy	1,000.00	4.38	4,380.00	10,000.00	https://www.sec.gov/Archives/edgar/data/1595097/000120919119055930/0001209191-19-055930-index.htm
2020-03-17	Craig Stuart Millian	Chief Commercial Officer	Buy	2,000.00	4.25	8,500.00	12,000.00	https://www.sec.gov/Archives/edgar/data/1595097/000120919120019954/0001209191-20-019954-index.htm
2018-05-15	Barbara White	Chief Medical Officer	Buy	2,586.00	5.87	15,174.39	179,521.00	https://www.sec.gov/Archives/edgar/data/1595097/000120919118030426/0001209191-18-030426-index.htm
2019-03-14	Barbara White	Chief Medical Officer	Buy	4,638.00	6.47	29,993.95	184,159.00	https://www.sec.gov/Archives/edgar/data/1595097/000120919119019374/0001209191-19-019374-index.htm
2019-05-17	Barbara White	Chief Medical Officer	Buy	1,389.00	7.20	10,000.80	185,548.00	https://www.sec.gov/Archives/edgar/data/1595097/000120919119031229/0001209191-19-031229-index.htm
2019-08-12	Barbara White	Chief Medical Officer	Buy	1,639.00	6.10	9,997.90	187,187.00	https://www.sec.gov/Archives/edgar/data/1595097/000120919119045697/0001209191-19-045697-index.htm
2019-11-12	Barbara White	Chief Medical Officer	Buy	3,424.00	4.38	14,991.64	190,611.00	https://www.sec.gov/Archives/edgar/data/1595097/000120919119056260/0001209191-19-056260-index.htm
2020-03-17	Barbara White	Chief Medical Officer	Buy	15,606.00	3.63	56,649.78	206,217.00	https://www.sec.gov/Archives/edgar/data/1595097/000120919120019914/0001209191-20-019914-index.htm
2018-11-14	Mark Tepper	President and CSO	Buy	10,000.00	1.00	10,000.00	2,110,400.00	https://www.sec.gov/Archives/edgar/data/1595097/000120919118058931/0001209191-18-058931-index.htm
2019-08-12	Robert Paul Discordia	Chief Operating Officer	Buy	15,000.00	5.86	87,894.00	30,150.00	https://www.sec.gov/Archives/edgar/data/1595097/000120919119045442/0001209191-19-045442-index.htm
2019-11-11	Robert Paul Discordia	Chief Operating Officer	Buy	2,500.00	4.62	11,558.50	32,650.00	https://www.sec.gov/Archives/edgar/data/1595097/000120919119055918/0001209191-19-055918-index.htm
2019-03-14	Sean F. Moran	Chief Financial Officer	Buy	1,500.00	6.67	10,005.00	349,510.00	https://www.sec.gov/Archives/edgar/data/1595097/000120919119019352/0001209191-19-019352-index.htm
2019-05-14	Sean F. Moran	Chief Financial Officer	Buy	100.00	7.12	712.00	349,610.00	https://www.sec.gov/Archives/edgar/data/1595097/000120919119029556/0001209191-19-029556-index.htm
2020-03-17	Robert Paul Discordia	Chief Operating Officer	Buy	2,840.00	3.54	10,053.60	35,490.00	https://www.sec.gov/Archives/edgar/data/1595097/000120919120019931/0001209191-20-019931-index.htm
2019-03-14	Craig Stuart Millian	Chief Commercial Officer	Buy	5,000.00	6.85	34,258.50	5,000.00	https://www.sec.gov/Archives/edgar/data/1595097/000120919119019602/0001209191-19-019602-index.htm
2019-05-14	Craig Stuart Millian	Chief Commercial Officer	Buy	1,000.00	7.23	7,226.60	6,000.00	https://www.sec.gov/Archives/edgar/data/1595097/000120919119029852/0001209191-19-029852-index.htm
2019-03-14	Yuval Cohen	Chief Executive Officer	Buy	1,530.00	6.49	9,929.70	63,190.00	https://www.sec.gov/Archives/edgar/data/1595097/000120919119019345/0001209191-19-019345-index.htm
2019-05-13	Yuval Cohen	Chief Executive Officer	Buy	995.00	6.99	6,954.85	64,185.00	https://www.sec.gov/Archives/edgar/data/1595097/000120919119029514/0001209191-19-029514-index.htm
2019-08-12	Yuval Cohen	Chief Executive Officer	Buy	1,175.00	6.06	7,115.80	65,360.00	https://www.sec.gov/Archives/edgar/data/1595097/000120919119045444/0001209191-19-045444-index.htm
2019-11-12	Yuval Cohen	Chief Executive Officer	Buy	1,430.00	4.26	6,091.80	66,790.00	https://www.sec.gov/Archives/edgar/data/1595097/000120919119055941/0001209191-19-055941-index.htm
2019-03-15	David P Hochman	Director	Buy	2,000.00	6.98	13,957.60	7,000.00	https://www.sec.gov/Archives/edgar/data/1595097/000120919119019885/0001209191-19-019885-index.htm
2020-03-17	Yuval Cohen	Chief Executive Officer	Buy	4,300.00	3.49	15,007.00	71,090.00	https://www.sec.gov/Archives/edgar/data/1595097/000120919120019502/0001209191-20-019502-index.htm
2019-08-12	Craig Stuart Millian	Chief Commercial Officer	Buy	1,500.00	6.00	9,000.00	7,500.00	https://www.sec.gov/Archives/edgar/data/1595097/000120919119045684/0001209191-19-045684-index.htm
2019-08-15	Craig Stuart Millian	Chief Commercial Officer	Buy	1,500.00	5.48	8,212.95	9,000.00	https://www.sec.gov/Archives/edgar/data/1595097/000120919119046252/0001209191-19-046252-index.htm

Corbus Pharmaceuticals Holdings, Inc

(NASDAQ:CRBP)